Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
NCT07473973 INZ-701 Arterial Calcification of Infancy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07473973 INZ-701 Arterial Calcification of Infancy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07473973 clinical trial report covering INZ-701, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07475000 Live attenuated varicella vaccine(Sinovac Biotech) Chickenpox Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07475000 Live attenuated varicella vaccine(Sinovac Biotech) Chickenpox Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07475000 clinical trial report covering Live attenuated varicella vaccine(Sinovac Biotech), Phase 3, endpoints, sponsor, geography, readout timing and d
Read →
NCT07475546 Naltrexone Hydrochloride disorder of aging Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07475546 Naltrexone Hydrochloride disorder of aging Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07475546 clinical trial report covering Naltrexone Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07475663 Piroxicam/Methyl Salicylate/Eugenol/Menthol Back Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07475663 Piroxicam/Methyl Salicylate/Eugenol/Menthol Back Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07475663 clinical trial report covering Piroxicam/Methyl Salicylate/Eugenol/Menthol, Phase 3, endpoints, sponsor, geography, readout timing and developm
Read →
NCT07473960 Tafolecimab Mixed hyperlipidemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07473960 Tafolecimab Mixed hyperlipidemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07473960 clinical trial report covering Tafolecimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
ChiCTR2600120457 Docetaxel Locally Advanced Lung Non-Small Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
ChiCTR2600120457 Docetaxel Locally Advanced Lung Non-Small Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
ChiCTR2600120457 clinical trial report covering Docetaxel, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07472517 Etoposide Extensive stage Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07472517 Etoposide Extensive stage Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07472517 clinical trial report covering Etoposide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20260928 Nebivolol hydrochloride Essential Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20260928 Nebivolol hydrochloride Essential Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20260928 clinical trial report covering Nebivolol hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07474077 Tranexamic Acid Postpartum Hemorrhage Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07474077 Tranexamic Acid Postpartum Hemorrhage Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07474077 clinical trial report covering Tranexamic Acid, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07475026 Tislelizumab Hepatocellular Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07475026 Tislelizumab Hepatocellular Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07475026 clinical trial report covering Tislelizumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07473427 Live attenuated varicella vaccine(Sinovac Biotech) Chickenpox Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07473427 Live attenuated varicella vaccine(Sinovac Biotech) Chickenpox Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07473427 clinical trial report covering Live attenuated varicella vaccine(Sinovac Biotech), Phase 3, endpoints, sponsor, geography, readout timing and d
Read →
NCT07473843 Zodasiran Homozygous familial hypercholesterolemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07473843 Zodasiran Homozygous familial hypercholesterolemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07473843 clinical trial report covering Zodasiran, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →